Industry collaboration

Merck KGaA

Karolinska Institutet and Merck KGaA, Germany, currently run 3 joint projects tackling cancer under the leadership of Randall Johnson, Urban Lendahl and Evren Alici. 

A KI-­Merck meeting will be held in Darmstadt Feb. 12th, 2019 to strengthen the current and potentially establish new joint projects.

KI-Roche Master Collaborative Agreement

The Master Collaborative Agreement for strategic collaboration in the Cancer Research field was signed by KI and Roche global research organization in December 2014.

The aim is to develop new and better therapies and more specific methods for analyses, as well as to identify novel signal pathways as potential drug targets.

The Master Collaborative Agreement between KI and Roche has been featured in a news article in 

Joint Steering Committee


  • Astrid Kiermaier (Roche)
  • Pavel Pisa (Roche)
  • Rune Toftgård (KI)
  • Klas Wiman (KI)


  • Gabriele Beer (Roche)

Alliance Directors: 

  • Björn Arvidsson (Roche) 
  • Sandra Falck (KI)

The Joint Steering Committee meets regularly (2-4 times yearly).


The first joint KI-Roche workshop in Oncology was held at Nobel Forum KI Solna October 19-20, 2015 with the ambition to allow interaction and discussion regarding possibilities for joint research projects.